Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.31B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.17B |
| 3 |
Privia Health
PRVA
|
+$1.13B |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$1.01B |
| 5 |
Sea Limited
SE
|
+$852M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$960M |
| 2 |
Avantor
AVTR
|
+$895M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$760M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$645M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 9.73% |
| 3 | Financials | 8.55% |
| 4 | Healthcare | 8.03% |
| 5 | Communication Services | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
AngloGold Ashanti
AU
$40.1B
| $23.4M | 0.01% |
1,260,680
+398,484
| +46% | +$8.76M |
|
1902
Flowserve
FLS
$9.71B
| $23.4M | 0.01% |
580,821
+52,180
| +10% | +$2.16M |
|
|
INOV
1903
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $23.4M | 0.01% |
686,880
+90,592
| +15% | +$2.8M |
|
|
GBT
1904
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $23.3M | 0.01% |
665,990
+195,041
| +41% | +$7.61M |
|
1905
F5
FFIV
$22.9B
| $23.2M | 0.01% |
124,556
-52,938
| -30% | -$10.2M |
|
1906
Loews
L
$23.9B
| $23.2M | 0.01% |
425,084
-95,292
| -18% | -$5.33M |
|
|
TRUE
1907
DELISTED
TrueCar
TRUE
| $23.2M | 0.01% |
4,102,135
+873,641
| +27% | +$4.4M |
|
|
MNR
1908
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $23.1M | 0.01% |
1,236,664
+855,843
| +225% | +$16.1M |
|
|
SFT
1909
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $23.1M | 0.01% |
269,332
+2,891
| +1% | +$231K |
|
|
CCMP
1910
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $23.1M | 0.01% |
153,066
+44,915
| +42% | +$7.44M |
|
1911
State Street SPDR S&P Pharmaceuticals ETF
XPH
$476M
| $23.1M | 0.01% |
445,633
-207,140
| -32% | -$10.4M |
|
1912
First Bancorp
FBP
$4.42B
| $23.1M | 0.01% |
1,935,147
-1,403,080
| -42% | -$17.3M |
|
|
DNMR
1913
DELISTED
Danimer Scientific, Inc.
DNMR
| $23M | 0.01% |
22,999
+4,687
| +26% | +$4.67M |
|
1914
Brighthouse Financial
BHF
$3.56B
| $23M | 0.01% |
505,681
-91,827
| -15% | -$4.31M |
|
|
MGI
1915
DELISTED
MoneyGram International, Inc. New
MGI
| $23M | 0.01% |
2,284,012
+2,245,860
| +5,887% | +$18.9M |
|
1916
Huntsman Corp
HUN
$1.71B
| $23M | 0.01% |
867,020
-98,330
| -10% | -$2.79M |
|
|
BBBY
1917
Bed Bath & Beyond
BBBY
$481M
| $23M | 0.01% |
274,244
+50,889
| +23% | +$3.7M |
|
1918
ArcelorMittal
MT
$52.9B
| $23M | 0.01% |
739,609
-273,583
| -27% | -$8.47M |
|
1919
Empire State Realty Trust
ESRT
$872M
| $23M | 0.01% |
1,913,237
+264,364
| +16% | +$3.11M |
|
|
TXNM
1920
TXNM Energy Inc
TXNM
$6.41B
| $22.9M | 0.01% |
470,578
-308,475
| -40% | -$15.2M |
|
|
ATVI
1921
PUT
DELISTED
Activision Blizzard
ATVI
| $22.9M | 0.01% |
239,500
+97,600
| +69% | +$9.24M |
|
1922
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
| $22.8M | 0.01% |
78,694
+20,998
| +36% | +$5.87M |
|
1923
iShares Floating Rate Bond ETF
FLOT
$10.2B
| $22.8M | 0.01% |
448,632
-44,843
| -9% | -$2.28M |
|
|
DRNA
1924
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $22.8M | 0.01% |
610,454
-458,115
| -43% | -$14M |
|
1925
Hess Midstream
HESM
$5.24B
| $22.8M | 0.01% |
902,006
+434,549
| +93% | +$10.5M |
|
Similar funds
Goldman Sachs's Q2 2021 Portfolio in Review
As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.
- Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
- Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
- Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
- Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
- Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
- Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
- Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.